Drug maker Johnson & Johnson says it will be able to provide 20 million doses of its single-shot COVID-19 vaccine to the U.S. government by the end of March, assuming it gets the green light from federal regulators.
Coronavirus: What's happening in Canada and around the world on Tuesday
Post a Comment